Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks 50 Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
The Fly
iTeos Therapeutics downgraded to Neutral from Overweight at Piper Sandler
3d ago
ITOS
Premium
The Fly
Vor Bio appoints Cumbo, Detheux to board of directors
3d ago
VOR
ITOS
Premium
Company Announcements
iTeos Therapeutics Announces Merger with Concentra Biosciences
3d ago
8K
ITOS
Premium
The Fly
iTeos to be acquired by Concentra for $10.047 per share in cash plus CVR
3d ago
ITOS
Premium
Company Announcements
GSK and Iteos Therapeutics’ Promising Phase 3 Study on NSCLC Treatment
7d ago
GSK
ITOS
Premium
Company Announcements
GSK and iTeos Therapeutics Advance Phase 3 NSCLC Study with Belrestotug and Dostarlimab
9d ago
GSK
ITOS
Premium
Company Announcements
iTeos Therapeutics Holds Annual Stockholders Meeting
1M ago
8K
ITOS
Premium
Company Announcements
Tim Van Hauwermeiren Resigns from iTeos Board
2M ago
8K
ITOS
Premium
Ratings
iTeos Therapeutics: Strategic Wind Down to Maximize Shareholder Value Amid Limited Pipeline Prospects
2M ago
ITOS
Premium
The Fly
iTeos Therapeutics downgraded to Equal Weight at Wells Fargo on wind down
2M ago
ITOS
Premium
The Fly
iTeos Therapeutics downgraded to Equal Weight from Overweight at Wells Fargo
2M ago
ITOS
Premium
Market News
iTeos Therapeutics Stock (ITOS) Booms 24% as it Winds Down and Sells Cancer Treatments
2M ago
ITOS
Premium
The Fly
iTeos Therapeutics downgraded to Neutral at Wedbush after wind down decision
2M ago
ITOS
Premium
The Fly
iTeos Therapeutics downgraded to Neutral from Outperform at Wedbush
2M ago
ITOS
Premium
Company Announcements
iTeos Therapeutics Announces Strategic Wind Down Plan
2M ago
8K
ITOS
Premium
The Fly
iTeos Therapeutics announces intention to wind down operations
2M ago
ITOS
Premium
The Fly
iTeos Therapeutics price target lowered to $13 from $16 at Wells Fargo
2M ago
ITOS
Premium
The Fly
iTeos Therapeutics price target lowered to $12 from $16 at Piper Sandler
2M ago
GSK
ITOS
Premium
The Fly
Leerink downgrades iTeos Therapeutics after termination of TIGIT program
2M ago
GSK
ITOS
Premium
The Fly
iTeos Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
2M ago
ITOS
Premium
The Fly
iTeos Therapeutics downgraded to Market Perform from Outperform at Leerink
2M ago
ITOS
Premium
Ratings
Strategic Shift and Strong Financials Position iTeos Therapeutics for Growth
2M ago
ITOS
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
